Clinical Trials in Salt Lake City

Showing 2021-2040 of 7,997 trials

Beliefs, Attitudes, and Response to Genetic Testing in SarcomaPatients

NCT06875700

Genomic research has shown that a portion of leiomyosarcomas can be attributed to an underlying cancer predisposition syndrome. However, the optimal approach for incorporating germline testing into the care of these patients. This study is assessing the beliefs about the heritability of leiomyosarcoma and other cancer risks, and attitudes towards germline testing among leiomyosarcoma patients.

Leiomyosarcoma

University of Utah300 participantsStarted Jul 2024

Salt Lake City, Utah, United States

COMPLETEDPhase 2< 1 mile

ALL Adult Consortium Trial: Adult ALL Trial

NCT00476190

The purpose of this study is to determine the safety and effectiveness of a multi-drug chemotherapy regimen in adult patients with Acute Lymphoblastic Leukemia (ALL). We will use a regimen that is often used in pediatric patients and we will add drugs called PEG-asparaginase and E. coli asparaginase. PEG-asparaginase has been given as an injection in the past and has been used in treatment with both children and adults with ALL. Information from those other research studies suggests that intravenous PEG-asparaginase has been administered safely in both children and adults. We hope to gain more information about the participants disease and how it responds to standard chemotherapy drugs used to treat ALL\>

Acute Lymphoblastic Leukemia

Dana-Farber Cancer Institute112 participantsStarted Apr 2007

Boston, Massachusetts, United States • Boston, Massachusetts, United States • Boston, Massachusetts, United States +12 more locations

Beliefs, Attitudes, and Response to Genetic Testing in SarcomaPatients

ALL Adult Consortium Trial: Adult ALL Trial

Find Trials by Condition in Salt Lake City

A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

Long-Term Safety and Antibody Persistence of TDV and the Impact of a Booster Dose

Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001)

Acute Cognitive Effects of Brain Edge

ProVIDE II Bridging Study

A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)

An Evaluation of the Safety of CSF-1 in Presbyopic Subjects

Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study

A Study to Evaluate the Efficacy and Safety of Gantenerumab in Participants at Risk for or at the Earliest Stages of Alzheimer's Disease (AD)

Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas

A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment

Nemvaleukin Alfa Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Cutaneous or Mucosal Melanoma - ARTISTRY-6

ZZ06 in Adult Patients With Advanced Solid Tumor Malignancies

Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease

A Dose-finding Study of CC-90009 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-risk Myelodysplastic Syndromes

Study of NKTR 255 in Combination With Cetuximab in Solid Tumors

A Study to Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease

Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B